AVEXXIN Trademark

Trademark Overview

On Friday, July 13, 2012, a trademark application was filed for AVEXXIN with the United States Patent and Trademark Office. The USPTO has given the AVEXXIN trademark a serial number of 85676030. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 31, 2020. This trademark is owned by Avexxin AS. The AVEXXIN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific, biotechnological and biomedical research in the field of treatment and prevention of inflammatory diseases; pharmaceutical drug development services, namely, development and identification of drugs and drug candidates in the field of treatment and prevention of inflammatory diseases; providing medical and scientific research information in the field of clinical trials, namely, in vivo and in vitro pre-clinical tests of drug candidates in the field of inflammatory diseases; clinical research in the field of treatment and prevention of inflammatory diseases
avexxin

General Information

Serial Number85676030
Word MarkAVEXXIN
Filing DateFriday, July 13, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 31, 2020
Registration Number4453241
Registration DateTuesday, December 24, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 8, 2013

Trademark Statements

Goods and ServicesScientific, biotechnological and biomedical research in the field of treatment and prevention of inflammatory diseases; pharmaceutical drug development services, namely, development and identification of drugs and drug candidates in the field of treatment and prevention of inflammatory diseases; providing medical and scientific research information in the field of clinical trials, namely, in vivo and in vitro pre-clinical tests of drug candidates in the field of inflammatory diseases; clinical research in the field of treatment and prevention of inflammatory diseases

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 31, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAvexxin AS
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressTrondheim N-7491
NO
Party NameAvexxin AS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressTrondheim N-7491
NO
Party NameAvexxin AS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressTrondheim N-7491
NO

Trademark Events

Event DateEvent Description
Friday, July 31, 2020CANCELLED SEC. 8 (6-YR)
Monday, December 24, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 24, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, October 8, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2013PUBLISHED FOR OPPOSITION
Wednesday, September 18, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 4, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 28, 2013ASSIGNED TO LIE
Monday, August 19, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 15, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 15, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 15, 2013TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, July 13, 2013NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, July 13, 2013FINAL REFUSAL E-MAILED
Saturday, July 13, 2013FINAL REFUSAL WRITTEN
Monday, June 10, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 10, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 10, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 10, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 1, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, June 1, 2013NON-FINAL ACTION E-MAILED
Saturday, June 1, 2013NON-FINAL ACTION WRITTEN
Thursday, May 2, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 1, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 1, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 8, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 8, 2012NON-FINAL ACTION E-MAILED
Thursday, November 8, 2012NON-FINAL ACTION WRITTEN
Tuesday, November 6, 2012ASSIGNED TO EXAMINER
Thursday, July 19, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 17, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

avexxin field inflammatory diseases research clinical prevention drug treatment namely candidates